Patients of eclampsia on Magnesium sulphate regime are monitored for all the following except:
**Core Concept**
Eclampsia is a severe complication of preeclampsia characterized by seizures in pregnant women. Magnesium sulfate is a first-line treatment for eclampsia due to its neuroprotective and muscle relaxant properties. Monitoring of magnesium sulfate therapy is crucial to prevent toxicity and ensure its efficacy.
**Why the Correct Answer is Right**
Magnesium sulfate therapy requires close monitoring of its serum levels, particularly in patients with renal impairment or other factors that may affect magnesium clearance. The primary reason for monitoring is to prevent magnesium toxicity, which can manifest as respiratory depression, cardiac arrest, and neuromuscular blockade. Continuous electrocardiogram (ECG) monitoring is essential to detect any changes in cardiac rhythm, such as prolongation of the QT interval.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is not a correct answer, as serum magnesium levels are indeed monitored in patients on magnesium sulfate therapy.
**Option B:** This option is incorrect, as urine output is a crucial parameter to monitor in patients receiving magnesium sulfate, as decreased urine output may indicate renal impairment or magnesium toxicity.
**Option C:** This option is not correct, as serum creatinine levels are monitored to assess renal function in patients on magnesium sulfate, which can be affected by magnesium toxicity.
**Clinical Pearl / High-Yield Fact**
A key aspect of magnesium sulfate therapy is to ensure that the patient's urine output is at least 50 mL/hour to prevent magnesium toxicity. This is because magnesium is primarily excreted through the kidneys, and decreased urine output can lead to accumulation of magnesium.
**Correct Answer: D.**